维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

13篇 您的检索式：作者名="Rabusin"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Hematopoietic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias显示文摘	Passweg J R Rabusin M	2008	Autoimmunity2008，41，8：	1
	2	Hematopoietic stem celhransplantation for immune thrombocytopenia and other refractory autoimmune cytope- nias显示文摘	PASSWEG JR RABUSIN M	2008	Autoimmunity2008，41，8：	1
	3	Hematopoietic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytope- nias显示文摘	PASSWEG JR RABUSIN M	2008	Autoimmunity2008，41，8：	1
	4	Haematopoietic SCT in autoimmune diseases in children:rationale and new perspectives显示文摘	Rabusin M Andolina M Maximova N	2008	Bone Marrow Transplant2008，41，2：	1
	5	Hematopoietic stem cell transplantation for multiple sclerosis显示文摘	A.S. Fassas J. R. Passweg A. Anagnostopoulos A. Kazis T. Kozak E. Havrdova E. Carreras F. Graus A. Kashyap H. Openshaw M. Schipperus E. Deconinck G. Mancardi A. Marmont J. Hansz M. Rabusin F. J. Zuazu Nagore J. Besalduch T. Dentamaro L. Fouillard B. Herte	2002	Journal of Neurology2002，，8：	1
	6	Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias显示文摘	Passweg JR Rabusin M	2008	Autoimmunity2008，41，8：	1
	7	Hematopoietic stem celltransplantation for immune thrombocytopenia and other refractory autoimmune cytopenias显示文摘	Passweg JR Rabusin M	2008	Autoimmunity2008，41，8：	1
	8	Haematopoetic stem cell transplantation for refractory autoimmune cytopenia显示文摘	Passweg JR Rabusin M Musso M	2004	Br J Haematol2004，125，6：	1
	9	Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series显示文摘	Sieni E Cetica V Piccin A Gherlinzoni F Sasso FC Rabusin M et aI	2012	PLoS ONE2012，7，44：	1
	10	Hematopoietic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias显示文摘	Passweg J R Rabusin M	2008	Autoimmunity2008，41，8：	1
	11	Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cy- topenias显示文摘	Passweg JR Rabusin M	2008	Autoimmunity2008，41，8：	1
	12	Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease显示文摘	RABUSIN M ANDOLINA M MAXIMOVA N	2000	Haematologica2000，85，11：	1
	13	Pharmacogenetics of thiopurines显示文摘Polychemotherapeutic protocols for the treatment of pediatric acute lymphoblastic leukemia(ALL)always include thiopurines.Specific approaches vary in terms of drugs,dosages and combinations.Such therapeutic schemes,including risk-adapted intensity,have been extremely successful for children with ALL who have reached an outstanding 5-year survival of greater than 90%in developed countries.Innovative drugs such as the proteasome inhibitor bortezomib and the bi-specific T cell engager blinatumomab are available to further improve therapeutic outcomes.Nevertheless,daily oral thiopurines remain the backbone maintenance or continuation therapy.Pharmacogenetics allows the personalization of thiopurine therapy in pediatric ALL and clinical guidelines to tailor therapy on the basis of genetic variants in TPMT and NUDT15 genes are already available.Other genes of interest,such as ITPA and PACSIN2,have been implicated in interindividual variability in thiopurines efficacy and adverse effects and need additional research to be implemented in clinical protocols.In this review we will discuss current literature and clinical guidelines available to implement pharmacogenetics for tailoring therapy with thiopurines in pediatric ALL.	Raffaella Franca Giulia Zudeh Sofia Pagarin Marco Rabusin Marianna Lucafò Gabriele Stocco Giuliana Decorti	2019	Cancer Drug Resistance2019，2，2：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费